Literature DB >> 1348253

Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero.

E D Zanjani1, M G Pallavicini, J L Ascensao, A W Flake, R G Langlois, M Reitsma, F R MacKintosh, D Stutes, M R Harrison, M Tavassoli.   

Abstract

Hemopoietic stem cells from human fetal liver were transplanted in utero into preimmune fetal sheep (48-54 days of gestation). The fate of donor cells was followed using karyotype analysis, by immunofluorescence labeling with anti-CD antibodies, and by fluorescent in situ hybridization using human-specific DNA probes. Engraftment occurred in 13 of 33 recipients. Of five live born sheep that exhibited chimerism, all expressed human cells in the marrow, whereas three expressed them in blood as well. Engraftment was multilineage (erythroid, myeloid, and lymphoid) and human hemopoietic progenitors (multipotent colony-forming units, colony-forming units-granulocyte, macrophage, and erythroid burst-forming units) capable of forming colonies in vitro were detected in all five lambs for greater than 2 yr. These progenitors responded to human-specific growth factors both in vitro and in vivo. Thus the administration of recombinant human IL-3 and granulocyte macrophage-colony-stimulating factor to chimeric sheep resulted in a 2.1-3.4-fold increase in the relative expression of donor (human) cells. These results demonstrate that the permissive environment of the preimmune fetal sheep provides suitable conditions for the engraftment and long-term multilineage expression of human hemopoietic stem cells in a large animal model. In this model, donor human cells appear to retain certain phenotypic and functional characteristics that can be used to manipulate the size of donor cell pool.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348253      PMCID: PMC442977          DOI: 10.1172/JCI115701

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Effects of methotrexate on transfected DNA stability in mammalian cells.

Authors:  M G Pallavicini; P S DeTeresa; C Rosette; J W Gray; F M Wurm
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

Review 2.  Xenogeneic transplantation. A review.

Authors:  H Auchincloss
Journal:  Transplantation       Date:  1988-07       Impact factor: 4.939

3.  Bone marrow and lymphoid cell injection of the pig foetus resulting in transplantation tolerance or immunity, and immunoglobulin production.

Authors:  R M Binns
Journal:  Nature       Date:  1967-04-08       Impact factor: 49.962

4.  Engraftment of immune-deficient mice with human hematopoietic stem cells.

Authors:  S Kamel-Reid; J E Dick
Journal:  Science       Date:  1988-12-23       Impact factor: 47.728

5.  Lack of correlation between natural killer activity and tumor growth control in nude mice with different immune defects.

Authors:  O Fodstad; C T Hansen; G B Cannon; C N Statham; G R Lichtenstein; M R Boyd
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

6.  Studies of human pluripotential hemopoietic stem cells (CFU-GEMM) in vitro.

Authors:  R C Ash; D A Detrick; E D Zanjani
Journal:  Blood       Date:  1981-08       Impact factor: 22.113

7.  Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid).

Authors:  K Dorshkind; S B Pollack; M J Bosma; R A Phillips
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

8.  Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3.

Authors:  Y C Yang; A B Ciarletta; P A Temple; M P Chung; S Kovacic; J S Witek-Giannotti; A C Leary; R Kriz; R E Donahue; G G Wong
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

9.  The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function.

Authors:  J M McCune; R Namikawa; H Kaneshima; L D Shultz; M Lieberman; I L Weissman
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

10.  Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice.

Authors:  S M Krams; K Dorshkind; M E Gershwin
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

View more
  30 in total

1.  Stem cells and ageing. The potential of stem cells to overcome age-related deteriorations of the body in regenerative medicine.

Authors:  Anthony D Ho; Wolfgang Wagner; Ulrich Mahlknecht
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

2.  Source of cell injected is a critical factors for short and long engraftment in xeno-transplantation.

Authors:  G Noia; M S Ligato; E Cesari; D Visconti; G Fortunato; M Tintoni; I Mappa; C Greco; M E Caristo; G Bonanno; M Corallo; L Minafra; A Perillo; M Terzano; S Rutella; G Leone; G Scambia; M Michejda; S Mancuso
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

3.  Immune ontogeny and engraftment receptivity in the sheep fetus.

Authors:  Jessica L Skopal-Chase; John S Pixley; Alireza Torabi; Mihai C Cenariu; Anupama Bhat; David S Thain; Nicole M Frederick; Daria M Groza; Esmail D Zanjani
Journal:  Fetal Diagn Ther       Date:  2009-02-25       Impact factor: 2.587

Review 4.  Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models.

Authors:  Andre Larochelle; Cynthia E Dunbar
Journal:  Semin Hematol       Date:  2013-04       Impact factor: 3.851

5.  The basis of allograft acceptance.

Authors:  Thomas E Starzl
Journal:  Forum (Genova)       Date:  1997

6.  Soluble factor(s) produced by adult bone marrow stroma inhibit in vitro proliferation and differentiation of fetal liver BFU-E by inducing apoptosis.

Authors:  V Roy; C M Verfaillie
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

Review 7.  The future of transplantation: with particular reference to chimerism and xenotransplantation.

Authors:  T E Starzl; A J Demetris; N Murase; L Valdivia; A W Thomson; J Fung; A S Rao
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

8.  Generation of CD34+ cells from human embryonic stem cells using a clinically applicable methodology and engraftment in the fetal sheep model.

Authors:  Jaehyup Kim; Esmail D Zanjani; Christine M Jeanblanc; A Daisy Goodrich; Peiman Hematti
Journal:  Exp Hematol       Date:  2013-04-20       Impact factor: 3.084

9.  Toward development and production of human T cells in swine for potential use in adoptive T cell immunotherapy.

Authors:  Brenda M Ogle; Bruce E Knudsen; Ryuta Nishitai; Kiyoshi Ogata; Jeffrey L Platt
Journal:  Tissue Eng Part A       Date:  2009-05       Impact factor: 3.845

Review 10.  Plasticity of human stem cells in the fetal sheep model of human stem cell transplantation.

Authors:  Graça Almeida-Porada; Christopher Porada; Esmail D Zanjani
Journal:  Int J Hematol       Date:  2004-01       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.